Life sciences companies GammaDelta Therapeutics and Adaptate Biotherapeutics have both agreed to take additional office space on the first floor of the WestWorks building at White City Place.
This will allow both of these innovative and expanding biotech companies to dedicate more space to vital laboratory space on the 4th floor, as their research and development activities continue to advance and grow.
The transactions will result in 100% occupation of the business suite facility on the 1st floor in the WestWorks. The series of 12 offices, ranging from 1,000 - 6,000 sq ft was designed to allow for smaller sized occupiers to acquire space in White City Place and improve the occupier ecosystem.
GammaDelta Therapeutics, which is focused on the development of cellular immunotherapies for cancer and other serious immune-related diseases moved into the 12,000 sq ft office and laboratory space on the 4th floor of WestWorks building in 2019. It has agreed to take a further 2,500 sq ft of office space at the WestWorks and expand its laboratory operations within its existing facilities.
Adaptate Biotherapeutics, a next-generation immunotherapy company focussed on developing therapeutic antibodies to treat cancer, will be increasing laboratory operations on the 4th floor and has agreed to take a separate 2,500 sq ft of office space at the WestWorks to support its rapid growth plans.
David Camp, CEO Stanhope, commented: “We are pleased to have signed these two deals which enable both GammaDelta Therapeutics and Adaptate Biotherapeutics to continue to grow their innovative products into potential life changing immunotherapies. Both companies are the embodiment of the ethos of White City Place, which is the home of innovation and collaboration in the life sciences, and we are delighted to see and help facilitate the continued success of these cutting-edge businesses.”
Dayle Hogg, COO GammaDelta Therapeutics, said: “The expansion of our research and development facilities at White City Place is an important step as we embark on the next phase of growth for GammaDelta Therapeutics in building our pipeline of innovative off the shelf cellular immunotherapies. Expansion within White City Place, facilitated by our partnership with Stanhope, provides us with access to additional world-class research and development facilities within a dynamic and growing hub of innovative life sciences businesses”
Natalie Mount, CEO Adaptate Biotherapeutics added: “We are delighted that we have been able to expand our R&D capacity at WestWorks to meet our ambitious growth plans, as we develop our pipeline of innovative therapeutic antibodies for patients with unmet medical needs.”